Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Cogent Biosciences, Inc. (COGT) had Free Cash Flow per Share of $-2.01 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-255.86M |
|
-- |
|
-- |
|
$275.94M |
|
$-275.94M |
|
$20.08M |
|
$-255.86M |
|
$-255.86M |
|
$-255.86M |
|
$-255.86M |
|
$-255.86M |
|
$-255.86M |
|
$-275.94M |
|
$-281.11M |
|
103.86M |
|
103.86M |
|
$-1.94 |
|
$-1.94 |
|
| Balance Sheet Financials | |
$296.47M |
|
$6.47M |
|
$31.43M |
|
$327.90M |
|
$55.71M |
|
-- |
|
$15.90M |
|
$71.61M |
|
$145.69M |
|
$256.29M |
|
$256.29M |
|
110.46M |
|
| Cash Flow Statement Financials | |
$-207.79M |
|
$38.28M |
|
$214.45M |
|
$53.23M |
|
$98.17M |
|
$44.94M |
|
$39.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-208.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-175.62% |
|
-99.83% |
|
-78.03% |
|
-99.83% |
|
$2.32 |
|
|
Free Cash Flow per Share |
$-2.01 |
$-2.00 |
|